YUHSpace

BROWSE

Export
291 462

Cited 40 times in

Cited 39 times in

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

DC Field Value Language
dc.contributor.authorLee, Sung Won-
dc.contributor.authorChoi, Jonggi-
dc.contributor.authorKim, Seung Up-
dc.contributor.authorLim, Young-Suk-
dc.date.accessioned2021-09-29T01:24:23Z-
dc.date.available2021-09-29T01:24:23Z-
dc.date.created2021-11-23-
dc.date.issued2021-07-
dc.identifier.issn2287-2728-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184344-
dc.description.abstractOver the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Association for the Study of the Liver-
dc.relation.isPartOfClinical and Molecular Hepatology-
dc.relation.isPartOfCLINICAL AND MOLECULAR HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEntecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorLee, Sung Won-
dc.contributor.googleauthorChoi, Jonggi-
dc.contributor.googleauthorKim, Seung Up-
dc.contributor.googleauthorLim, Young-Suk-
dc.identifier.doi10.3350/cmh.2021.0179-
dc.relation.journalcodeJ00557-
dc.identifier.eissn2287-285X-
dc.subject.keywordEntecavir-
dc.subject.keywordTenofovir-
dc.subject.keywordHepatitis B-
dc.subject.keywordCarcinoma, Hepatocellular-
dc.subject.keywordEfficacy-
dc.subject.keywordOutcome-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.affiliatedAuthorKim, Seung Up-
dc.identifier.scopusid2-s2.0-85110089866-
dc.identifier.wosid000670121400002-
dc.citation.volume27-
dc.citation.number3-
dc.citation.startPage402-
dc.citation.endPage412-
dc.identifier.bibliographicCitationClinical and Molecular Hepatology, Vol.27(3) : 402-412, 2021-07-
dc.identifier.rimsid71731-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorEntecavir-
dc.subject.keywordAuthorTenofovir-
dc.subject.keywordAuthorHepatitis B-
dc.subject.keywordAuthorCarcinoma, Hepatocellular-
dc.subject.keywordAuthorEfficacy-
dc.subject.keywordAuthorOutcome-
dc.subject.keywordPlusDISOPROXIL FUMARATE-
dc.subject.keywordPlusRISK-
dc.subject.keywordPlusCIRRHOSIS-
dc.type.docTypeReview-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalWebOfScienceCategoryGastroenterology & Hepatology-
dc.relation.journalResearchAreaGastroenterology & Hepatology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links